Levin Capital Strategies’s PAVmed PAVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-333
Closed -$44.1K 293
2023
Q3
$44.1K Hold
333
0.01% 257
2023
Q2
$61.1K Sell
333
-334
-50% -$66.8K 0.01% 256
2023
Q1
$112K Buy
667
+45
+7% +$9.47K 0.01% 213
2022
Q4
$134K Buy
622
+289
+87% +$109K 0.02% 202
2022
Q3
$129K Sell
333
-12
-3% -$6.8K 0.02% 195
2022
Q2
$145K Sell
345
-389
-53% -$188K 0.02% 219
2022
Q1
$436K Buy
734
+689
+1,531% +$512K 0.04% 173
2021
Q4
$50K Sell
45
-26
-37% -$56.5K ﹤0.01% 320
2021
Q3
$272K Sell
71
-5
-7% -$15.8K 0.03% 242
2021
Q2
$218K Hold
76
0.02% 276
2021
Q1
$151K Sell
76
-155
-67% -$233K 0.02% 273
2020
Q4
$220K Sell
231
-22
-9% -$18.8K 0.02% 243
2020
Q3
$203K Buy
253
+11
+5% +$9.79K 0.03% 224
2020
Q2
$230K Buy
242
+111
+85% +$111K 0.03% 153
2020
Q1
$117K Sell
131
-2
-2% -$1.64K 0.02% 154
2019
Q4
$72K Buy
133
+111
+505% +$46.2K 0.01% 200
2019
Q3
$10K Sell
22
-314
-93% -$143K ﹤0.01% 204
2019
Q2
$172K Buy
336
+280
+500% +$148K 0.02% 188
2019
Q1
$27K Buy
+56
New +$25.6K ﹤0.01% 192
2018
Q3
Sell
-483
Closed -$206K 303
2018
Q2
$206K Buy
483
+327
+210% +$200K ﹤0.01% 254
2018
Q1
$115K Buy
+156
New +$134K ﹤0.01% 288
2017
Q4
Sell
-25
Closed -$60K 344
2017
Q3
$60K Sell
25
-30
-55% -$62.1K ﹤0.01% 334
2017
Q2
$112K Buy
55
+5
+10% +$10.4K ﹤0.01% 294
2017
Q1
$112K Hold
50
﹤0.01% 285
2016
Q4
$155K Hold
50
﹤0.01% 288
2016
Q3
$314 Buy
+50
New +$318K ﹤0.01% 262

Other funds holding PAVM

Levin Capital Strategies's PAVM Position: Q4 2023 in Review

Levin Capital Strategies sold out of PAVmed (PAVM) in Q4 2023, closing a stake of 333 shares — an estimated $44.1K sold.

Levin Capital Strategies first reported a position in PAVM in Q3 2016 and held it in 26 quarters. The position peaked at $436K in Q1 2022. 23 funds tracked by Wall St. Rank hold PAVM as of Q4 2023.

  • Levin Capital Strategies reported no remaining PAVmed position as of Q4 2023 after selling out during the quarter.
  • Levin Capital Strategies sold 333 PAVmed shares in Q4 2023, an estimated $44.1K.
  • Levin Capital Strategies first reported a position in PAVmed in Q3 2016 and held it in 26 quarters.
  • Levin Capital Strategies's PAVmed position peaked at $436K in Q1 2022.
  • 23 funds tracked by Wall St. Rank held PAVmed as of Q4 2023.

Based on Levin Capital Strategies's 13F filing for Q4 2023, filed 6 Feb 2024.